From silico to benchtop: cosmosiin as a PD-1/PDL-1 immune checkpoint inhibitor revealed through DFT, network pharmacology analysis, and molecular docking integrated experimental verification
Reem I. Alsantali(Taif University), Saleh A. Ahmed(Umm al-Qura University)
Cited by 6
Related Papers
1,2,4-Triazolo-[1,5-<i>a</i>]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction
|Journal of Medicinal Chemistry|2017|34
Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
|Communications Biology|2021|34